Back to Search
DAVID HONG, M.D.
M.D.
Medical Oncology Physician
NPI: 1255439469IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L3682(TX)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1999
Research & Publications (20)
Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib.
PMID 18445656·Mol Cancer Ther·2008
5-case
Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib.
PMID 18559769·Arch Dermatol·2008
5-case
Interleukin-6 and its receptor in cancer: implications for translational therapeutics.
PMID 17849470·Cancer·2007
6-review
Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors.
PMID 16902987·Cancer·2006
3-trial
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
PMID 16118804·Cancer·2005
8-other
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.
PMID 14523768·Clin Infect Dis·2003
5-case
Pelvic actinomycosis confirmed after surgery: single center experience.
PMID 19565255·Arch Gynecol Obstet·2010
8-other
Valgus osteotomy combined with intramedullary nail for Shepherd's crook deformity in fibrous dysplasia: 14 femurs with a minimum of 4 years follow-up.
PMID 19629503·Arch Orthop Trauma Surg·2010
8-other
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.
PMID 19499186·Invest New Drugs·2010
3-trial
Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.
PMID 19484470·Cancer Chemother Pharmacol·2010
3-trial
Chaperone-mediated Cu+ delivery to Cu+ transport ATPases: requirement of nucleotide binding.
PMID 19525226·J Biol Chem·2009
8-other
Postoperative retroperitoneal hematoma following transforaminal percutaneous endoscopic lumbar discectomy.
PMID 19558294·J Neurosurg Spine·2009
5-case
A phase I clinical trial of darinaparsin in patients with refractory solid tumors.
PMID 19584162·Clin Cancer Res·2009
3-trial
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.
PMID 19476625·J Transl Med·2009
8-other
Chest computed tomography before evacuation of hydatidiform mole.
PMID 19480243·Eur J Gynaecol Oncol·2009
8-other
GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors.
PMID 19543423·J Korean Med Sci·2009
5-case
Sensor fusion of phase measuring profilometry and stereo vision for three-dimensional inspection of electronic components assembled on printed circuit boards.
PMID 19623230·Appl Opt·2009
8-other
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
PMID 19546406·J Clin Oncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1255439469
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile